These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24349936)

  • 1. Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS.
    Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
    Mass Spectrom (Tokyo); 2013; 2(Spec Iss):S0017. PubMed ID: 24349936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
    Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
    Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
    Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers.
    Fabresse N; Larabi IA; Abe E; Lamy E; Rigothier C; Massy ZA; Alvarez JC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
    Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis.
    Hyun HS; Paik KH; Cho HY
    Korean J Pediatr; 2013 Apr; 56(4):159-64. PubMed ID: 23646054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?
    Lenglet A; Fabresse N; Taupin M; Gomila C; Liabeuf S; Kamel S; Alvarez JC; Drueke TB; Massy ZA
    Drugs; 2019 Jun; 79(8):855-862. PubMed ID: 31062264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.
    Daneshamouz S; Eduok U; Abdelrasoul A; Shoker A
    NanoImpact; 2021 Jan; 21():100299. PubMed ID: 35559786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of free and protein bound uremic toxins in human serum by LC-MS/MS: Comparison of rapid equilibrium dialysis and ultrafiltration.
    Fabresse N; Uteem I; Lamy E; Massy Z; Larabi IA; Alvarez JC
    Clin Chim Acta; 2020 Aug; 507():228-235. PubMed ID: 32371217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Dental Scores and Saliva Uremic Toxins.
    Rigothier C; Catros S; Bénard A; Samot J; Quintin O; Combe C; Larabi I; Massy Z; Alvarez JC
    Toxins (Basel); 2023 Nov; 15(11):. PubMed ID: 37999529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Function and Uremic Toxins after Kidney Transplantation: An Exploratory Study.
    Te Linde E; van Roij CJM; Meijers BKI; De Loor H; Kessels RPC; Wetzels JFM
    Kidney360; 2020 Dec; 1(12):1398-1406. PubMed ID: 35372897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of indoxyl-beta-D-glucuronide in uremic serum: suppression of its production by oral sorbent and efficient removal by hemodialysis.
    Niwa T; Miyazaki T; Tsukushi S; Maeda K; Tsubakihara Y; Owada A; Shiigai T
    Nephron; 1996; 74(1):72-8. PubMed ID: 8883023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.
    van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two rapid, accurate liquid chromatography tandem mass spectrometry methods for the quantification of seven uremic toxins: An application for describing their accumulation kinetic profile in a context of acute kidney injury.
    André C; Bennis Y; Titeca-Beauport D; Caillard P; Cluet Y; Kamel S; Choukroun G; Maizel J; Liabeuf S; Bodeau S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122234. PubMed ID: 32615535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
    Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS.
    Ragi N; Pallerla P; Babi Reddy Gari AR; Lingampelly SS; Ketavarapu V; Addipilli R; Chirra N; Kantevari S; Yadla M; Sripadi P
    Metabolomics; 2023 Feb; 19(3):14. PubMed ID: 36826619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of uremic toxin research by mass spectrometry.
    Niwa T
    Mass Spectrom Rev; 2011; 30(3):510-21. PubMed ID: 21328600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-volume hemodiafiltration decreases the pre-dialysis concentrations of indoxyl sulfate and p-cresyl sulfate compared to hemodialysis: a post-hoc analysis from the HDFit randomized controlled trial.
    Lima JD; Guedes M; Rodrigues SD; Flórido ACS; Moreno-Amaral AN; Barra AB; Canziani ME; Cuvello-Neto A; Poli-de-Figueiredo CE; Pecoits-Filho R; Nakao LS
    J Nephrol; 2022 Jun; 35(5):1449-1456. PubMed ID: 35239175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
    Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G
    J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.